Related Experiment Video
Updated: Oct 14, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases
Patricia Biedermann1, Rose Ong1, Alexander Davydov2
1Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123, Allschwil, Switzerland.
Transforming pulmonary hypertension registry data to the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) enables real-world evidence generation. This process facilitates rare disease research and collaborations.
Area of Science:
- Health Informatics
- Observational Data Standards
- Rare Disease Research
Background:
- The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) standardizes observational health data for cross-database analysis.
- Generating real-world evidence (RWE) is crucial for rare diseases like pulmonary hypertension (PH), where data is often limited.
- Pulmonary arterial hypertension (PAH) presents unique challenges for RWE generation due to its rare subgroups.
Purpose of the Study:
- To document the process and outcomes of transforming PH registry data into the OMOP CDM.
- To identify and address challenges encountered during the data transformation process.
- To propose potential solutions for improving future data harmonization efforts in rare diseases.
Main Methods:
- Three observational studies (OPUS, OrPHeUS, EXPOSURE) were converted from Clinical Data Interchange Standards Consortium (CDISC) SDTM to OMOP CDM format.
- OMOP CDM version 5.3.1 and its associated vocabularies were utilized for the transformation.
- Imputation rules for missing dates and custom target concepts for enhanced granularity were applied.
Main Results:
- A total of 6457 out of 6622 patient records (97.5%) from three registries were successfully mapped to the OMOP CDM.
- Custom concepts were developed for PAH subgroups and World Health Organization functional classes.
- Exclusion of non-event records resulted in minimal data loss: 4% (OPUS), 2% (OrPHeUS), and 1% (EXPOSURE).
Conclusions:
- SDTM data from three registries were effectively transformed to the OMOP CDM with minimal data exclusion.
- The documented strategy and methods can be adapted for data transformation in other disease areas, particularly rare diseases.
- Mapping registry data to OMOP CDM enhances research collaboration and supports the development of federated data networks.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Methods of Documentation II: POMR
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

